Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

View:
Post by Finnexas on Feb 16, 2022 10:07am

43-101

https://stockhouse.com/news/press-releases/2022/02/16/voyageur-pharmaceuticals-announces-publication-of-the-jubilee-mountain-ni-43-101
Comment by biggdogg on Feb 16, 2022 10:12am
New company spin out coming? Battery metals, excellent.
Comment by postie1 on Feb 16, 2022 11:14am
This will be interesting to watch. These guys just keep on working and moving forward behind the scenes. Doers who are not spending all day on social media pumping.
Comment by postie1 on Feb 16, 2022 11:20am
I liked that paragraph. Tells me they are not taking there eyes off the game plan. "Voyageur is discussing and analysing a cost-effective path forward to have these Projects independently managed. Voyageur's focus is on its Frances Creek project and full integration of the radiology pharmaceutical drug and device market."
Comment by biggdogg on Feb 16, 2022 1:29pm
Obviously shareholders are going to have a huge benefit by owning a new base metal company. Very good looking project. Why anyone would sell shares now, and not wait is a mystery to me.
Comment by WarrantOfficer on Feb 16, 2022 11:19am
Great idea for a new company spin out. Might be able to get some free shares. I am somewhat cautious as they do not lose focus on their primary objective at Francis Creek or utilize funds earmarked for Francis Creek. Copper at 20K a ton in 2023?...I state copper has surpassed this at 4.50 an oz now.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1